Comprehensive Summary
This study broadly investigates a new computational approach called Temporal Basis Function Models (TBFMs) to enhance closed-loop neural stimulation therapies. The research was conducted by analyzing 40 optogenetic stimulation sessions in two rhesus macaques, using micro-electrocorticography to record brain activity and predict responses to paired optical pulses. The findings revealed that TBFMs required less than 20 minutes of data collection and under 5 minutes of training, significantly faster than a linear state-space model (90 minutes) and an autoencoder-LSTM model (over 11 hours). In terms of accuracy, TBFMs achieved a mean test set R² of 0.462 for 164ms forecasts, outperforming linear and LSTM models, and showed stronger discrimination for shorter (40ms) predictions with an R² of 0.787. Simulations demonstrated that TBFMs could effectively detect target brain states and modify neural trajectories, with state-dependence evident in 97.4% of channels. Ignoring the initial brain state reduced prediction performance close to zero, underscoring the importance of this consideration. The discussion highlights that simple, low-latency models like TBFMs offer a practical path toward safe, adaptive neural stimulation therapies by addressing challenges of sample efficiency, training time, and inference speed, paving the way for improved clinical implementations in the future.
Outcomes and Implications
Closed-loop stimulation offers promise for conditions such as Parkinson’s disease, but clinical adoption has been limited by lengthy training times, high computational demands, and poor efficiency. This study is important because TBFMs achieve low-latency (<0.2 ms) predictions with modest data requirements, demonstrating near real-time feasibility. Clinically, such methods could shorten calibration in deep brain stimulation procedures and support individualized adaptive therapy without prolonged hospital time or unsafe trial-and-error stimulation. While current results are in non-human primates, authors suggest this efficiency may speed translation to outpatient neurology and neurosurgical workflows within the coming years, should further validation in humans confirm robustness and safety.